Background and Aims The damage that SARS Cov2 virus exerts at the renal level has been the subject of analysis in many studies. We analysed the extent of Acute Kidney Injury (AKI), possible factors involved and mortality in patients hospitalised with Covid-19 during the first wave of the pandemic. We reassessed renal function, as well as inflammatory and nutritional status of patients 18 months after admission, together with the capacity for recovery of renal function. Method Observational and retrospective study of patients admitted to the ward or intensive care unit (ICU) for Covid-19 during the month of March 2020. We defined the stage of renal damage according to the KDIGO guidelines. Among the possible risk factors associated with AKI and mortality, we analysed haematological analytical parameters (lymphopenia and plateletopenia), inflammatory markers such as CRP and ferritin, and nutritional status, vitamin D and cholesterol, among others. We evaluated ICU mortality using the Odin scale and the life expectancy at 10 years using the Charlson scale. We used the Chi-square test and Fisher's test, considering significant values p<0.05. Results A total of 576 patients were admitted during the study period, of whom 10.6% were admitted to the ICU (n 61). A total of 45.9% (n 28) had some degree of AKI, the most frequent being grade 2 (22.9%), followed by grade 3 (18%) and grade 1 (4.9%). Of all patients requiring admission to the ICU, 78.6% of those with AKI died. The Odin scale was significantly associated with AKI and mortality, but the Charlson scale was not. The maximum dose of Cisatracurium was significantly associated with AKI. Among the patients admitted to inpatient areas (n 515), 9.9% (n 51) had AKI and 31.4% of these patients died. In most cases the degree of renal damage was mild (82.4% grade 1 vs. 13.7% grade 2 and 3.9% grade 3). When we studied the patients who presented with AKI (n 79), we observed that CK and LDH values were significantly higher, indicating a more inflammatory state. Of the 79 patients, 48.1% (n 38) died, with significant differences in serum CRP and D-dimer levels. Of the 41 patients who survived, we conducted an 18-month follow-up study that only 36.6% (n 15) completed, with a mean age of 69.7 years, 73.3% being male and 20% with previous chronic kidney disease (CKD). At the end of follow-up 86% of them recovered renal function, according to pre-admission figures, including those patients with baseline CKD. Only 13% of the patients who completed follow-up showed a slight worsening of renal function with respect to their baseline situation. We observed differences in the values of calcium, vitamin B12 and vitamin D in the group of patients who recovered renal function compared to those who showed deterioration with respect to their situation prior to admission (p<0.02). Conclusion The incidence of AKI in COVID patients requiring admission to the ICU was four times higher than in patients admitted to the ward. The severity of renal damage was greater in the ICU, predominantly AKI 2-3 vs AKI 1, with mortality 2.5 times higher than in the ward. The group of patients who develop AKI have an elevation of inflammatory markers, which increases in the group of deceased patients. In ICU, the Odin scale was significantly related to AKI and mortality. - The mortality rate in the group of patients with AKI was high. Most of the patients have recovered pre-admission renal function after 18 months of follow-up, with differences in nutritional parameters such as calcium, vitamin B12 and vitamin D.
Background and Aims Kidney transplantation (KT) is considered to be the best option for renal replacement therapy (RRT) in patients with advanced chronic kidney disease, surpassing any dialysis technique in quality and life expectancy. However, results in terms of how pre-KT dialysis technique influences graft and recipient survival are mixed. Some studies show a higher incidence of vascular complications in the immediate post-transplant period and higher rates of acute rejection in patients coming from peritoneal dialysis (PD) versus those coming from hemodialysis (HD) while others observe a lower incidence of delayed graft function in the PD group of patients versus those on HD. Our objective is to analyze if there are differences in immediate post-kidney transplantation and at 6 months of follow-up depending on the pre-KT dialysis technique, PD versus HD. Method Observational study of all patients with KT of cadaveric donor from the beginning of the KT program in our Center, from August 2011 to August 2019. We analyzed the characteristics of donors and recipients according to the technique (PD/HD), the evolution and complications in the immediate post-KT, as well as results at 6 months of follow-up in terms of complications, renal function and survival of the recipient and the graft. For statistical analysis we used SPSS 25. We compared qualitative variables by means of Xi2 test, and quantitative variables by t of Student, or U of Mann-Whitney if the variables did not follow a normal distribution. A value of p <0.05 was considered significant. Results 121 patients were included, 71 of whom were in the HD group, versus 50 who were in the PD group. The recipients in the HD group were significantly older (57.2 vs 51.6 years, p 0,02) and stayed on dialysis longer (33.8 vs 26.8 months). We observed no difference in the recipient's cardiovascular history, except for increased smoking in the HD group (52.1% vs. 24%). The donor-recipient immune profile was similar in both groups. As for the incidence of delayed graft function, it was significantly lower in the PD group (14.9% vs 34.3%), finding no difference in renal function at hospital discharge or in days of admission. In the first 6 months of follow-up, we found no differences in terms of vascular, urological or infectious complications. There were also no differences in the incidence of acute rejection, renal function measured by creatinine (HD 1.47 vs DP 1.50 mg/dl) and proteinuria (HD 200 vs DP 216 mg/24 hours). Graft and recipient survival at 6 months of TR follow-up were similar in both groups. Conclusion In our experience, we have not found differences in the evolution at 6 months of the KT according to the modality of dialysis , nor greater incidence of vascular, immunological or other complications, with a survival of graft and receptor superimposable between both groups, PD or HD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.